Premium
Potential of immunotherapy for sarcoma
Author(s) -
Hoffman Robert M.,
Singh Arun S.,
Eilber Fritz C.
Publication year - 2017
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30603
Subject(s) - medicine , immunotherapy , sarcoma , cancer , cancer immunotherapy , refractory (planetary science) , soft tissue sarcoma , soft tissue , oncology , cancer research , immunology , pathology , biology , astrobiology
This editorial examines Miwa et al's article entitled “Phase 1/2 Study of Immunotherapy With Dendritic Cells Pulsed With Autologous Tumor Lysate in Patients With Refractory Bone and Soft Tissue Sarcoma: A Safe Method for Inducing an Immunological Response but With Limited Effects on Clinical Outcomes,” which appears in the current issue of Cancer . The state of the art of autologous cancer vaccines is briefly reviewed, and suggestions for improved immunological therapy for sarcomas are discussed. See also pages 1576‐84.